Eli Lilly
Trade Eli Lilly 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies.
LLY Key Statistics
Stock Snapshot
With a market cap of 957.71B, Eli Lilly(LLY) trades at $1,013.04. The stock has a price-to-earnings ratio of 48.24 and currently yields dividends of 54.2%.
On 2026-02-05, Eli Lilly(LLY) stock moved within a range of $1,013.04 to $1,113.00. With shares now at $1,013.04, the stock is trading 0.0% above its intraday low and -9.0% below the session's peak.
Trading volume for Eli Lilly(LLY) stock has reached 4.82M, versus its average volume of 3.42M.
Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,133.95 and a low of $623.78.
Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,133.95 and a low of $623.78.
LLY News
Eli Lilly and Co. (NYSE:LLY) stock is trading lower on Thursday, possibly on profit-taking after the stock rallied roughly 10% on Wednesday. On Wednesday, Eli L...
Structure Therapeutics has a promising GLP-1 drug that is about to enter phase 3 trials. Novo Nordisk and Eli Lilly are the two leading companies in the GLP-1...
Eli Lilly’s (LLY) stock is down 6% on news that telehealth company Hims & Hers Health (HIMS) is selling a $49 weight-loss pill. Claim 50% Off TipRanks Premium U...
Analyst ratings
75%
of 32 ratingsMore LLY News
Hims & Hers has a GLP-1 weight loss pill -- and it's the cheapest one out there. One day after reporting Q4 earnings, Eli Lilly (LLY 6.40%) shares tumbled 6% t...
The Eli Lilly Analyst: Analyst Louise Chen maintained a Sector Outperform rating, while raising the price target from $1,165 to $1,300. The Eli Lilly Thesis: T...
Scotiabank raised the firm’s price target on Eli Lilly (LLY) to $1,300 from $1,165 and keeps an Outperform rating on the shares. The firm is raising its price t...
Eli Lilly Heads Group Of 17 Hot Prospects Joining IBD 50, Stock Spotlight, Other Best Stock Lists 2/04/2026 See which stocks like Eli Lilly have just been adde...
Wells Fargo analyst Mohit Bansal raised the firm’s price target on Eli Lilly (LLY) to $1,280 from $1,200 and keeps an Overweight rating on the shares. The firm...
Eli Lilly and Novo Nordisk may want to enjoy their duopoly while they can. Eli Lilly's (LLY +10.33%) obesity drug, Zepbound, generated sales of $13.5 billion i...
The healthcare giant gained nearly $100 billion in market value. Shares of Eli Lilly (LLY +10.38%) climbed over 10% on Wednesday after the medicine maker deliv...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.